<scp>Early‐salvage</scp> therapy with venetoclax‐based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients-Reference-Cited by-同舟云学术

Early‐salvage therapy with venetoclax‐based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients

Published:2022-09-26 Issue:5 Volume:199 Page:772-776
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wei Shuning¹,Gu Runxia¹,Song Yang¹^ORCID,Yan Zhangsong¹,Hu Yimin¹,Lin Dong¹,Liu Kaiqi¹^ORCID,Zhou Chunlin¹,Zhang Guangji¹,Wang Ying¹,Wang Jianxiang²^ORCID,Mi Yingchang²^ORCID

Affiliation:

1. National Clinical Research Center for Blood Diseases Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China

2. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin China

Funder

National Key Research and Development Program of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18487

Reference14 articles.

1. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811

2. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia

3. Cytogenetic and early-response characteristics of adolescents and young adults with acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) study.

4. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

5. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax;Reactions Weekly;2023-02-04